Investor FAQs

Show All
Show all

Fate Therapeutics trades on the NASDAQ Global Market and the stock ticker symbol is FATE. The company's initial public offering (IPO) priced on October 1, 2013.

12278 Scripps Summit Drive
San Diego, CA 92131

The company's fiscal year ends on December 31st.

Fate Therapeutics does not expect to declare or pay any cash or other dividends on our common stock.

Fate Therapeutics does not currently have a direct stock purchase plan.

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information section of our Investor Relations website or directly from the SEC at

Equiniti Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: 800-937-5449